The WFH Global Forum is an essential event for anyone with an interest in the developments that are shaping the global bleeding disorders community today. With several new therapeutic options available—and more in the pipeline—it’s time to collectively assess these advances, identify their strengths and limitations, determine what will facilitate or hinder their adoption, and evaluate their impact on patients.
This year, gene therapy has been fully integrated into the event. It will be included as part of discussions on the overall treatment landscape, and as a unique therapeutic option on its own. This brings the WFH Global Forum to a new level, and it means that you will have a unique opportunity to gain a truly global perspective on the cutting-edge developments taking place in our field today.
Here’s a quick peek at the Program for November’s event:
By attending the 13th WFH Global Forum, you will also have the chance to win a free registration to the WFH 2024 World Congress in Madrid, which will be the most comprehensive international event on bleeding disorders in 2024.
The 13th edition of the WFH Global Forum is supported by funding from BioMarin, CSL Behring, Sobi and Spark Therapeutics.